Q4 2021 Ascendis Pharma A/S Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Q4 2021 Ascendis Pharma Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Mr. Tim Lee, Senior Director of Investor Relations. So Lee, the floor is yours.
Thank you, operator. Thank you, everyone, for joining our full year 2021 financial results conference call today. I'm Tim Lee, Senior Director, Investor Relations of Ascendis Pharma. Joining me on today's call is Jan Mikkelsen, President and Chief Executive Officer; Scott Smith, Senior Vice President and Chief Financial Officer; Jesper Hoiland, Global Chief Commercial Office Officer; Dr. Dana Pizzuti, Head of Development Operations and Chief Medical Officer; Dr. Juha Punnonen, Head of Oncology; and Dr. Stina Singel, Head of Clinical Development Oncology.
Before we begin, I would like to remind you that this conference call will contain forward-looking statements that are intended to be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
